APA

Asakura H., Ontachi Y., Mizutani T., Kato M., Saito M., Kumabashiri I., Morishita E., Yamazaki M., Aoshima K. & Nakao S. (20010719). An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. : Critical care medicine.

Chicago

Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K and Nakao S. 20010719. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. : Critical care medicine.

Harvard

Asakura H., Ontachi Y., Mizutani T., Kato M., Saito M., Kumabashiri I., Morishita E., Yamazaki M., Aoshima K. and Nakao S. (20010719). An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. : Critical care medicine.

MLA

Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K and Nakao S. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. : Critical care medicine. 20010719.